ScienceDex / Researcher record
Alison B Edelman
- Oregon Health & Science University · Obstetrics & Gynecology (NIH department code)
- Oregon Health & Science University (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,061,388 | 1 | #14,052 |
| 2025 | $962,568 | 4 | #17,227 |
| 2026 | $312,903 | 1 | #41,433 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY2025 · selected4 records
- FY20261 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 7566925Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Obstetrics & Gynecology
FY2025 award records by amount
NIH award records listing Alison B Edelman as a PI. Multi-PI records show the full award amount for context.
- 5R01HD105866-04R01Contact PIPharmacogenomics of an ovulation modulator and the impact on delay of ovulationOregon Health & Science University · Obstetrics & Gynecology (NIH department code)$787.9Kaward amount
- 75N94020D00016-0-759402500001-1N01Contact PINICHD: R&D: TO EVALUATE IN OBESE AND NON-OBESE WOMEN THE PHARMACOKINETICS (PK), PHARMACODYNAMIC (PD) EFFECTS, SAFETY, AND CONTRACEPTIVE EFFICACY OF LEVONORGESTREL BUTANOATE (LB) FORMULATED AS A LONG-A$97.8Kaward amount
- 75N94020D00016-P00002-759402300001-1N01Contact PINICHD:R&D: OVAPRENE PHASE 1: PROTOCOL FINALIZATION, REGULATORY APPROVAL, START-UP, AND COMMENCEMENT OF RECRUITMENT, SCREENING, AND ENROLLMENT FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL (NON-SEVER$70.4Kaward amount
- 75N94020D00016-0-759402500002-1N01Contact PINICHD:R&D:CENTRAL LABORATORY FOR A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION:NON-SEVERABLE$6.5Kaward amount
Award organization
Organizations that administered FY2025 awards listing Alison B Edelman as a PI.
FY2025 award administered by Oregon Health & Science University (OR).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardOregon Health & Science University
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Alison B Edelman.